| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 07/16/2002 | US6420136 Controlling gene expression and propagation; obtain cell, incubate with modulator, monitor gene expression inhibition and antiproliferative activities |
| 07/16/2002 | US6420135 Streptococcus pneumoniae polynucleotides and sequences |
| 07/16/2002 | US6420124 KVLQT1—a long qt syndrome gene |
| 07/16/2002 | US6420120 Use of a polypeptide as cell receptor for adenoviruses |
| 07/16/2002 | US6419921 DNA-constructs of blood clotting factors and P-Selectin |
| 07/16/2002 | US6419919 Method for the augmentation of gene expression |
| 07/16/2002 | CA2236158C Method for treating retinal ganglion cell injury using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 07/16/2002 | CA2090009C Methods for inhibiting rejection of transplanted tissue |
| 07/11/2002 | WO2002054073A2 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | WO2002053775A2 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 07/11/2002 | WO2002053770A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests |
| 07/11/2002 | WO2002053760A2 Chimeric cytolytic viruses for cancer treatment |
| 07/11/2002 | WO2002053756A2 Regulation of human glucosamine-6-phosphate deaminase |
| 07/11/2002 | WO2002053755A2 Regulation of human otu-like cysteine protease |
| 07/11/2002 | WO2002053753A2 Novel human lipase and polynucleotides encoding the same |
| 07/11/2002 | WO2002053752A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 07/11/2002 | WO2002053749A2 Regulation of human serine-threonine protein kinase |
| 07/11/2002 | WO2002053748A1 Regulation of human 3-ss-hydroxysteroid dehydrogenase-isomerase |
| 07/11/2002 | WO2002053743A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 07/11/2002 | WO2002053733A2 Regulation of human b7-h2 protein |
| 07/11/2002 | WO2002053728A2 Gene disruption methodologies for drug target discovery |
| 07/11/2002 | WO2002053711A2 Use of transcription factor yb-1 in adenoviral systems |
| 07/11/2002 | WO2002053703A2 Aav2 vectors and methods |
| 07/11/2002 | WO2002053701A2 Epididymal lipocalin gene and uses thereof |
| 07/11/2002 | WO2002053699A2 Chondrocyte-specific and non-specific elements in the fgfr-3 promoter region |
| 07/11/2002 | WO2002053596A2 Antibodies to insulin-like growth factor i receptor |
| 07/11/2002 | WO2002053581A2 Spliceosome mediated rna trans-splicing |
| 07/11/2002 | WO2002053576A1 Viral delivery system for infectious transfer of large genomic dna inserts |
| 07/11/2002 | WO2002053191A1 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof |
| 07/11/2002 | WO2002053171A2 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002034901A3 Protein kinase |
| 07/11/2002 | WO2002030970A3 Human histone deacetylase gene |
| 07/11/2002 | WO2002024933A3 Viral vectors having tissue tropism for t-lymphocytes, b- and mast cells |
| 07/11/2002 | WO2002022783A3 Liver gene expression associated with the inhibition of hbv replication or transcription |
| 07/11/2002 | WO2002020724A3 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2002008456A8 Method for identifying metastatic tumor cells |
| 07/11/2002 | WO2002008286A3 Zinc finger domain recognition code and uses thereof |
| 07/11/2002 | WO2002006454A3 Regulation of human carboxylesterase-like enzyme |
| 07/11/2002 | WO2002000862A3 32447, a novel human acyltransferase and uses thereof |
| 07/11/2002 | WO2001085207A3 Modulation of antigen processing using phagocytic cells |
| 07/11/2002 | WO2001079445A3 Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/11/2002 | WO2001079274A3 Tuberculosis antigens and methods of use thereof |
| 07/11/2002 | WO2001078756A3 Agent for postoperative use after the removal of bone tumours |
| 07/11/2002 | WO2001077377A3 Diagnosis of diseases associated with dna replication by assessing dna methylation |
| 07/11/2002 | WO2001066745A3 Presenilin/crk binding polypeptides (pcbp) and methods of use thereof |
| 07/11/2002 | WO2001059094A3 Method of regulating transcription in a cell by altering remodeling of cromatin |
| 07/11/2002 | WO2001046383A9 Compositions and methods involving an essential staphylococcus aureus gene and its encoded protein |
| 07/11/2002 | WO2001044473A3 Polypeptides and nucleic acids encoding same |
| 07/11/2002 | WO2001043540A3 Methods for producing transgenic animals |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2001032920A3 Agents implicated in endometriosis |
| 07/11/2002 | WO2001025438A3 Ifn-alpha homologues |
| 07/11/2002 | WO2001021213A3 Inhibition of secretion from non-neuronal cells |
| 07/11/2002 | WO2001016322A3 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 07/11/2002 | WO2001011086A9 Methods of screening for angiogenesis modulators |
| 07/11/2002 | WO2001010907A9 Therapeutic polypeptides and methods for using same |
| 07/11/2002 | WO2000073321A9 Human tumor necrosis factor receptor tr10 |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | WO2000066179A9 Noninvasive genetic immunization, expression products therefrom, and uses thereof |
| 07/11/2002 | WO2000064488A9 Somatic transgene immunization and related methods |
| 07/11/2002 | WO2000063438A3 Method of classifying a thyroid carcinoma using differential gene expression |
| 07/11/2002 | WO2000061747A9 Clasp-2 transmembrane proteins |
| 07/11/2002 | WO2000052187A9 Enhanced system for construction of adenovirus vectors |
| 07/11/2002 | WO2000049937A9 Trpm-2 antisense therapy |
| 07/11/2002 | US20020091375 Stent lining |
| 07/11/2002 | US20020091247 Polycyclic aromatic hydrocarbon induced molecules |
| 07/11/2002 | US20020091246 Dendritic cell co-stimulatory molecules |
| 07/11/2002 | US20020091244 Nucleotide sequences for use in diagnosis and treatment of cancer and immunological disorders |
| 07/11/2002 | US20020091236 Nucleotide sequences coding preferential polypeptide for use in detection of bactericides |
| 07/11/2002 | US20020091160 Administering orally a source of at least one of L-arginine and L-lysine as other than a natural food source |
| 07/11/2002 | US20020091098 Also administering to the subject an effective amount of an mda-7 protein. |
| 07/11/2002 | US20020091094 Glutamic acid decarboxylase (GAD) based delivery system |
| 07/11/2002 | US20020091083 Substance which regulates the type-I collagen gene transcription regulating ability |
| 07/11/2002 | US20020091082 Inhibiting VEGF-KDR signaling pathway components, e.g., PKC-zeta and/or PI3 kinase 1. |
| 07/11/2002 | US20020090724 Activation of regulatory T cells by alpha-melanocyte stimulating hormone |
| 07/11/2002 | US20020090722 Pluripotent mammalian cells |
| 07/11/2002 | US20020090719 Expression vectors containing hybrid ubiquitin promoters |
| 07/11/2002 | US20020090717 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/11/2002 | US20020090715 Method for the preparation of a viral vector by inter-molecular homologous recombination |
| 07/11/2002 | US20020090714 Bacteriophage vectors generated by bacteriophage/plasmid recombination |
| 07/11/2002 | US20020090701 14257 novel protein kinase molecules and their uses therefor |
| 07/11/2002 | US20020090696 Treating neurological disorders using human apoptosis inhibiting protein |
| 07/11/2002 | US20020090695 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 07/11/2002 | US20020090694 Human Hox C10 and polynucleotides encoding |
| 07/11/2002 | US20020090683 Tumor necrosis factor-gamma |
| 07/11/2002 | US20020090674 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090673 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090672 Nucleic acids, proteins, and antibodies |
| 07/11/2002 | US20020090610 Polypeptide for use in the detection, diagnosis, prevention and treatment of vial disease |
| 07/11/2002 | US20020090383 Phosphatidyl oligoglycerols |
| 07/11/2002 | US20020090377 Emulsion and micellar formulations for the delivery of biologically active substances to cells |
| 07/11/2002 | US20020090373 ADAMTS polypeptides, nucleic acids encoding them, and uses thereof |
| 07/11/2002 | US20020090364 Cells designed as traps and their use as medicines |
| 07/11/2002 | US20020090363 Sustained bioactive agent delivery device and methods of making and using the same |
| 07/11/2002 | US20020090355 Reversal of cancer phenotype by inhibiting expression of prostate tumor inducing gene |
| 07/11/2002 | DE10061110A1 Expression der Keratingene 8 und 18 zur Therapie von Tumoren, insbesondere des Mammakarzinoms Expression of keratin genes 8 and 18 for the treatment of tumors, especially of breast cancer |
| 07/11/2002 | CA2689741A1 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/11/2002 | CA2558640A1 Spliceosome mediated rna trans-splicing |